Rupesh Rajesh Kotecha, MD - Baptist ...

Dr. Rupesh R Kotecha, MD

Claim this profile

Miami Cancer Institute

Studies Lung Cancer
Studies Brain Tumor
24 reported clinical trials
43 drugs studied

Area of expertise

1Lung Cancer
Rupesh R Kotecha, MD has run 10 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
EGFR negative
2Brain Tumor
Rupesh R Kotecha, MD has run 9 trials for Brain Tumor. Some of their research focus areas include:
Stage IV
IDH positive
PIK3CA positive

Affiliated Hospitals

Image of trial facility.
Miami Cancer Institute At Baptist Health, Inc.
Image of trial facility.
Miami Cancer Institute

Clinical Trials Rupesh R Kotecha, MD is currently running

Image of trial facility.

PRDR Radiotherapy

for Recurrent Brain Cancer

The purpose of this research study is to see if a specific type of radiation therapy, called "proton pulsed reduced dose rate" or "PRDR radiotherapy" has any benefits at dose levels and number of fractions thought to be acceptable in earlier research studies. The researchers want to find out what effects (good and bad) PRDR has on people with cancer in the brain called a "recurrent high-grade glioma" meaning that it grows fast, can spread quickly, and it has come back or gotten worse after being treated previously.
Recruiting1 award N/A7 criteria
Image of trial facility.

Prophylactic Radiotherapy

for Spinal Metastases

Early palliative care has been shown to improve the quality of life and even survival for patients with metastatic cancer. More and more supportive oncology teams in cancer centers now advocate for early integration of radiation therapy (RT) in a patient's palliative management course. While multiple randomized studies have evaluated the efficacy of different RT regimens in the treatment of symptomatic bone lesions, few studies have examined the impact of early, upfront RT for asymptomatic or minimally symptomatic (non- opioid dependent) spine metastases and its efficacy in preventing skeletal-related events (SREs). Since the pathophysiology of spinal metastatic disease is distinct from other bony metastatic disease, the proposed trial seeks to understand whether it is beneficial to patients with minimally symptomatic disease to undergo upfront RT to reduce the risks of SREs and their sequelae, including hospitalizations.
Recruiting1 award Phase 1 & 2

More about Rupesh R Kotecha, MD

Clinical Trial Related1 year of experience running clinical trials · Led 24 trials as a Principal Investigator · 10 Active Clinical Trials
Treatments Rupesh R Kotecha, MD has experience with
  • Radiation Therapy
  • 18F Fluciclovine
  • Fractionated Stereotactic Radiation Therapy
  • Stereotactic Radiosurgery
  • Durvalumab
  • NovoTTF-200T

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Rupesh R Kotecha, MD specialize in?
Is Rupesh R Kotecha, MD currently recruiting for clinical trials?
Are there any treatments that Rupesh R Kotecha, MD has studied deeply?
What is the best way to schedule an appointment with Rupesh R Kotecha, MD?
What is the office address of Rupesh R Kotecha, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security